obtusifolin and Neoplasm-Metastasis

obtusifolin has been researched along with Neoplasm-Metastasis* in 1 studies

Other Studies

1 other study(ies) available for obtusifolin and Neoplasm-Metastasis

ArticleYear
Obtusifolin suppresses phthalate esters-induced breast cancer bone metastasis by targeting parathyroid hormone-related protein.
    Journal of agricultural and food chemistry, 2014, Dec-10, Volume: 62, Issue:49

    This study is the first to demonstrate that parathyroid hormone-related protein (PTHrP), produced by human breast cancer cells after exposure to phthalate esters, contributes to bone metastasis by increasing osteoclastogenesis. This is also the first to reveal that obtusifolin reverses phthalate esters-mediated bone resorption. Human breast cancer cells were treated with dibutyl phthalate (DBP), harvested in conditioned medium, and cultured to osteoblasts or osteoclasts. Cultures of osteoblasts with DBP-MDA-MB-231-CM increased the osteoclastogenesis activator RANKL (receptor activator of nuclear factor κ-B ligand) and M-CSF (macrophage colony-stimulating factor). PTHrP was secreted in MDA-MB-231 cells. DBP-MDA-MB-231-CM reduced osteoblasts to produce osteoprotegerin, an osteoclastogenesis inhibitor, while DBP mediated PTHrP up-regulation, increasing IL-8 secretion in MDA-MB-231 and contributing to breast cancer-mediated osteoclast differentiation and bone resorption. Obtusifolin, a major bioactive compound present in Cassia tora L., suppressed phthalate esters-mediated bone resorption. Therefore, obtusifolin may be a novel anti-breast-cancer bone metastasis agent.

    Topics: Anthraquinones; Bone Neoplasms; Bone Resorption; Cassia; Cell Differentiation; Down-Regulation; Drugs, Chinese Herbal; Esters; Female; Humans; Macrophage Colony-Stimulating Factor; Neoplasm Metastasis; Osteoclasts; Osteoprotegerin; Parathyroid Hormone-Related Protein; Phthalic Acids; RANK Ligand

2014